Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 4/2009

01.04.2009 | 2008 ssat quickshot presentation

Leukocyte Depletion in Allogeneic Blood Transfusion Does Not Change the Negative Influence on Survival Following Transthoracic Resection for Esophageal Cancer

verfasst von: Frederike C. Ling, Arnulf H. Hoelscher, Daniel Vallböhmer, Daniel Schmidt, Susanne Picker, Birgit S. Gathof, Elfriede Bollschweiler, Paul M. Schneider

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Perioperative transfusion of allogeneic blood has been hypothesized to have an immunomodulatory effect and influence survival in several cancer types. This study evaluates the association between receipt of leucocyte-depleted and non-depleted allogeneic blood and survival following esophagectomy for cancer.

Methods

A retrospective analysis was performed including 291 patients with esophageal cancers who underwent transthoracic en bloc esophagectomy and extended mediastinal lymphadenectomy. Neoadjuvant chemoradiation was administered in 152 (52.2%) patients. Perioperative blood transfusions were quantified and the potential prognostic cutoff for transfused units was calculated according to LeBlanc.

Results

The median number of perioperative blood transfusions was 2 (0–24), and 106 patients (36.4%) received no transfusions. Patients with one or less blood transfusion showed a significantly improved survival compared to patients receiving more than one unit (p < 0.009). In multivariate analysis, blood transfusion categories showed significance (p < 0.015) next to pT, pN, pM category, and residual tumor categories (R-categories). Separate analysis of 183 patients treated after the mandatory introduction of leukocyte-depleted blood transfusions detected a strong tendency, but no significant difference in survival for patients getting one or less or more than one transfusion (p = 0.056). Receipt of leukocyte-depleted versus non-depleted units, however, had no influence on survival (p = 0.766).

Conclusions

The need for perioperative allogeneic blood transfusions is significantly associated with poorer survival following resection for esophageal cancer by univariate and multivariate analysis. Our data suggest that the reduction of leukocytes in allogeneic transfusions is not sufficient to overcome the negative influence on survival.
Literatur
5.
Zurück zum Zitat Tachibana M, Tabara H, Kotoh T, Kinugasa S, Dhar DK, Hishikawa Y, Masunaga R, Kubota H, Nagasue N. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. AJG 1999;94:759–765. Tachibana M, Tabara H, Kotoh T, Kinugasa S, Dhar DK, Hishikawa Y, Masunaga R, Kubota H, Nagasue N. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. AJG 1999;94:759–765.
6.
Zurück zum Zitat Dresner SM, Lamb PJ, Shenfine J, Hayes N, Griffin SM. Prognostic significance of perioperative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 2000;26:492–497. doi:10.1053/ejso.1999.0929.PubMedCrossRef Dresner SM, Lamb PJ, Shenfine J, Hayes N, Griffin SM. Prognostic significance of perioperative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 2000;26:492–497. doi:10.​1053/​ejso.​1999.​0929.PubMedCrossRef
8.
Zurück zum Zitat Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion. Blood 1994;84:344–348.PubMed Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion. Blood 1994;84:344–348.PubMed
9.
Zurück zum Zitat Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993;81:1880–1882.PubMed Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993;81:1880–1882.PubMed
10.
Zurück zum Zitat Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Möller-Nielsen C, Hanberg-Sörensen F, Hokland M. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513–516. doi:10.1002/bjs.1800790613.PubMedCrossRef Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Möller-Nielsen C, Hanberg-Sörensen F, Hokland M. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513–516. doi:10.​1002/​bjs.​1800790613.PubMedCrossRef
12.
Zurück zum Zitat Council of Europe. Guide to the preparation, use and quality assurance of blood components. 13th edn. Strassbourg, France: Council of Europe Publishing, 2007. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 13th edn. Strassbourg, France: Council of Europe Publishing, 2007.
13.
Zurück zum Zitat Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP, Hoelscher AH. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684–692. doi:10.1097/01.sla.0000186170.38348.7b.PubMedCrossRef Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP, Hoelscher AH. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684–692. doi:10.​1097/​01.​sla.​0000186170.​38348.​7b.PubMedCrossRef
14.
Zurück zum Zitat LeBlanc M. Tree-based methods for prognostic stratification. In Crowley J, ed. Handbook of statistics in clinical oncology 2001. New York: Marcel Decker, 2001, pp 457–471. LeBlanc M. Tree-based methods for prognostic stratification. In Crowley J, ed. Handbook of statistics in clinical oncology 2001. New York: Marcel Decker, 2001, pp 457–471.
17.
Zurück zum Zitat Motoyama S, Okuyama M, Kitamura M, Saito R, Kamata S, Murata K, Ogawa JI. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer. J Surg Oncol 2004;87:26–31. doi:10.1002/jso.20064.PubMedCrossRef Motoyama S, Okuyama M, Kitamura M, Saito R, Kamata S, Murata K, Ogawa JI. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer. J Surg Oncol 2004;87:26–31. doi:10.​1002/​jso.​20064.PubMedCrossRef
18.
Zurück zum Zitat Takemura M, Osugi H, Higashino M, Takada N, Lee S, Kinoshita H. Effects of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 2005;11:293–300.PubMed Takemura M, Osugi H, Higashino M, Takada N, Lee S, Kinoshita H. Effects of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 2005;11:293–300.PubMed
19.
Zurück zum Zitat Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the imunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996;83:973–977. doi:10.1002/bjs.1800830727.PubMedCrossRef Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the imunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996;83:973–977. doi:10.​1002/​bjs.​1800830727.PubMedCrossRef
20.
21.
Zurück zum Zitat Jensen LS, Puho E, Pedersen L, Mortensen FV, Sorensen HT. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 2005;365:681–682.PubMed Jensen LS, Puho E, Pedersen L, Mortensen FV, Sorensen HT. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 2005;365:681–682.PubMed
22.
Zurück zum Zitat Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE, Klementschitsch P, van de Maas AHM, van de Velde CJH. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573–578. doi:10.1016/S0140-6736(94)91965-8.PubMedCrossRef Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE, Klementschitsch P, van de Maas AHM, van de Velde CJH. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573–578. doi:10.​1016/​S0140-6736(94)91965-8.PubMedCrossRef
Metadaten
Titel
Leukocyte Depletion in Allogeneic Blood Transfusion Does Not Change the Negative Influence on Survival Following Transthoracic Resection for Esophageal Cancer
verfasst von
Frederike C. Ling
Arnulf H. Hoelscher
Daniel Vallböhmer
Daniel Schmidt
Susanne Picker
Birgit S. Gathof
Elfriede Bollschweiler
Paul M. Schneider
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 4/2009
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-008-0787-1

Weitere Artikel der Ausgabe 4/2009

Journal of Gastrointestinal Surgery 4/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.